Foxwayne Enterprises Acquisition Corp Cl A (FOXW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FOXW | ZTS | TAK | NBIX | UTHR |
| Company | Foxwayne Enterprises Acquisition Corp Cl A | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Neurocrine Bioscienc | United Therapeutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 10.17 | 163.10 | 13.29 | 143.79 | 255.10 |
| High | 10.25 | 169.99 | 13.31 | 144.09 | 260.34 |
| Low | 10.17 | 161.38 | 13.21 | 139.63 | 253.93 |
| Last | 10.25 | 167.23 | 13.27 | 139.83 | 258.13 |
| Change | +0.05 | +8.73 | +0.08 | -3.20 | +2.99 |
| % Change | +0.49% | +5.51% | +0.61% | -2.24% | +1.17% |
| Volume | 700 | 5,323,100 | 1,033,500 | 882,400 | 717,100 |
| 20-Day Average Volume | 11,285 | 4,607,025 | 1,649,675 | 795,465 | 541,125 |
| Previous Close | 10.20 | 158.50 | 13.19 | 143.03 | 255.14 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 10.27 | 156.57 | 13.31 | 136.71 | 237.67 |
| 20-Day Raw Stochastic | 26.12% | 89.04% | 34.42% | 64.28% | 92.62% |
| 20-Day Relative Strength | 50.10% | 53.14% | 41.35% | 53.72% | 65.92% |
| Weighted Alpha | +2.60 | -11.34 | -20.97 | +43.92 | +23.85 |
| Today's Opinion | 88% Buy | 64% Sell | 100% Sell | 88% Buy | 88% Buy |
| Previous Opinion | 88% Buy | 72% Sell | 100% Sell | 88% Buy | 88% Buy |
| Last Month's Opinion | 24% Buy | 56% Sell | 80% Sell | 88% Buy | 16% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.47% since 01/19/23 | +9.04% since 04/25/24 | +1.53% since 04/25/24 | +1.50% since 04/25/24 | +9.40% since 04/25/24 |
| Low | 10.17 on 01/27/23 | 152.63 on 04/26/24 | 13.01 on 04/26/24 | 135.17 on 04/26/24 | 233.31 on 04/30/24 |
| High | 10.74 on 01/20/23 | 169.99 on 05/02/24 | 13.31 on 05/02/24 | 145.22 on 05/01/24 | 260.34 on 05/02/24 |
| 1-Month | |||||
| %Chg | +1.08% since 12/27/22 | +1.35% since 04/02/24 | -2.07% since 04/02/24 | +1.52% since 04/02/24 | +12.93% since 04/02/24 |
| Low | 10.14 on 12/30/22 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 130.13 on 04/19/24 | 227.75 on 04/03/24 |
| High | 10.74 on 01/20/23 | 169.99 on 05/02/24 | 13.77 on 04/08/24 | 145.22 on 05/01/24 | 260.34 on 05/02/24 |
| 3-Month | |||||
| %Chg | +0.99% since 10/26/22 | -11.54% since 02/02/24 | -7.07% since 02/02/24 | -1.35% since 02/02/24 | +20.95% since 02/02/24 |
| Low | 10.00 on 11/25/22 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 128.00 on 02/07/24 | 208.62 on 02/08/24 |
| High | 10.74 on 01/20/23 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 148.37 on 03/21/24 | 260.34 on 05/02/24 |
| 6-Month | |||||
| %Chg | +0.20% since 07/27/22 | +3.93% since 11/02/23 | -4.33% since 11/02/23 | +23.32% since 11/02/23 | +13.13% since 11/02/23 |
| Low | 10.00 on 11/25/22 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 103.63 on 11/10/23 | 208.62 on 02/08/24 |
| High | 10.74 on 01/20/23 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 148.37 on 03/21/24 | 260.34 on 05/02/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 29,020 | 76,484,144 | 41,997,384 | 13,914,065 | 11,452,196 |
| Shares Outstanding, K | 2,831 | 457,359 | 3,164,837 | 99,507 | 44,366 |
| Annual Sales | 0 | 8,544,000,000 | 29,803,340,000 | 1,887,100,000 | 2,327,500,000 |
| Annual Net Income | -1,050,000 | 2,344,000,000 | 2,345,930,000 | 249,700,000 | 984,800,000 |
| Last Quarter Sales | 0 | 2,213,000,000 | 7,556,070,000 | 515,200,000 | 614,700,000 |
| Last Quarter Net Income | -376,199 | 525,000,000 | 718,900,000 | 147,700,000 | 217,100,000 |
| 60-Month Beta | 0.09 | 0.86 | 0.56 | 0.28 | 0.54 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.38 on 05/02/24 | 0.51 on 02/01/24 | 1.20 on 05/01/24 | 6.17 on 05/01/24 |
| Latest Earnings Date | N/A | 05/02/24 | 05/09/24 | 05/01/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 29.79 | 6.76 | 39.40 | 12.06 |